Asthma occurrence in children and early life systemic antibiotic use: an incidence density study.

Authors:
Bentouhami H; Bungwa MK; Casas L; Coenen S; Weyler J.

Journal:
Allergy Asthma Clin Immunol

Publication Year: 2023

DOI:
10.1186/s13223-023-00773-8

PMCID:
PMC9987135

PMID:
36879341

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Allergy Asthma Clin Immunol

Abbreviation: Allergy Asthma Clin Immunol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Acuity of asthma exacerbations in Alberta, Canada is increasing: a population-based study.
Adatia A; Moolji J; Satia I. (2024) - Transparency Score: 3/6
Different expression levels of interleukin-36 in asthma phenotypes.
Li J; Wang Z; Dong H and 3 more (2024) - Transparency Score: 3/6
Inborn errors of immunity in adulthood.
Wang JJF; Dhir A; Hildebrand KJ and 5 more (2024) - Transparency Score: 3/6
Prevalence of asthma in people with type 1 diabetes mellitus: a scoping review.
Kamei JM; Maués RD; de Oliveira Silva G and 5 more (2024) - Transparency Score: 3/6
Resource utilization and cost assessment of a proactive penicillin allergy de-labeling program for …
Lanoue D; Mir A; van Walraven C and 3 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateThe medical ethics committee of the University Hospital of Antwerp granted approval for all parts of the project (UA A06 10) and informed written consent was obtained from the parents for each assessment. Consent for publicationNot applicable. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

Evidence found in paper:

"Funding The PIPO project was funded by the Flanders Research Foundation (FWO) in Belgium (Number 7.0015.00 and Number G015221N) and the Flemish Government (PBO98/26/143)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025